The stock is on a verge of a potential breakout above the $36.50 resistance and to an all-time high, as all 4 moving averages now point to the upward trend.
Fundamentally, the stock is expected to report both strong earnings and sales in around 2 weeks’ time, and the growth prospects seem bright after the acquisitions of Bayer's animal health business and Kindred Biosciences.
The group trend is also favorable as evidenced by a continuous and relentless run in companies like IDXX and ZTS.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 68 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .